WALL, NJ — (Marketwired) — 05/04/15 — BIO-key International, Inc. (OTCQB: BKYI), a leader in fingerprint biometric identification technologies for hospitals, clinics and private medical practices, and HealthCast, Inc., the #1 KLAS-ranked Single Sign-On solution for 2014, together are delivering innovative solutions for SSO and secure two-factor authentication for EPCS (electronic prescription of controlled substances) in hospitals across the United States. Their customers include leading hospitals and hospital systems, such as Rady Children–s Hospital in San Diego, California, the first in the US to deploy an EPCS solution with its Epic EMR.

“We understand that the doctors and nurses appreciate innovative technology that streamlines what was once a time-consuming and less secure process,” stated Jim Skidmore VP Sales, BIO-key. “We are pleased to provide our solutions with those of HealthCast to meet these needs.”

“Technology and technology partners are an important part of making every healthcare organization more efficient and productive. HealthCast–s solutions have always focused on improving clinician productivity as they interact with electronic medical records while strengthening patient data privacy. Our partnership with BIO-key enables us to bring the best EPCS solution to the healthcare market,” said Joan Mehn, CEO of HealthCast.

HealthCast creates software authentication and access management solutions for healthcare providers to enable fast, simple, and secure access to patient data stored in electronic medical records. Its single sign-on solution has the distinction of again being ranked #1, this time in the 2014 KLAS SSO category. HealthCast solutions provide unparalleled speed to EHRs and virtual desktops, secure fast-user switching, automated workflow within applications, unique proximity badge and PIN features, remote access solutions with second factor authentication, EPCS and order verification, and “roaming sessions” to allow users immediate re-access to their work at any computer throughout the enterprise.

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key–s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world–s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key–s technology is offered directly or by market leading partners around the world. ()

Certain statements contained in this press release and in other public statements by the Company and Company officers include or may contain certain forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “will,” “may,” “future,” “plan,” “intend” and “expect” and similar expressions generally identify forward-looking statements. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Although we believe that our plans, intentions and expectations reflected in the forward-looking statements are reasonable, we cannot be sure that they will be achieved. Particular uncertainties that could cause our actual results to be materially different than those expressed in our forward-looking statements include: our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition between us and other companies in the biometric technology industry; market acceptance of biometric products generally and our products under development; delays in the development of products and statements of assumption underlying any of the foregoing, as well as other factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014 filed with the Securities and Exchange Commission. All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. Except as required by law, we undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Jay Meier
VP Corporate Development
BIO-key Intl., Inc.
651-789-6116

  bio-key-international, inc